ABEONA THERAPEUTICS INC. Property, Plant and Equipment, Gross
ABEONA THERAPEUTICS INC. (ABEO) had Property, Plant and Equipment, Gross of $28.73 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-08-13
- 2026-06-30: Property, Plant and Equipment, Gross $28.73M.
- 2026-03-31: Property, Plant and Equipment, Gross $28.47M.
- 2025-12-31: Property, Plant and Equipment, Gross $27.14M.
- 2025-09-30: Property, Plant and Equipment, Gross $26.69M.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2026-06-30 | $28.73M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $28.47M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $27.14M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $26.69M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $25.55M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $22.46M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $19.41M 10-K · filed 2026-03-17 |
| 2024-09-30 | $18.50M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $17.94M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $17.25M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $16.52M 10-K · filed 2025-03-20 |
| 2023-09-30 | $16.74M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $16.87M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $17.84M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $17.62M 10-K · filed 2024-03-18 |
| 2022-09-30 | $18.46M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $19.13M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $22.90M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $22.80M 10-K · filed 2023-03-29 |
| 2020-12-31 | $18.65M 10-K · filed 2022-03-31 |
| 2019-12-31 | $17.31M 10-K · filed 2021-03-24 |
| 2018-12-31 | $11.00M 10-K · filed 2020-03-16 |
| 2017-12-31 | $1.76M 10-K · filed 2019-03-18 |
| 2016-12-31 | $900.00K 10-K · filed 2018-03-16 |
| 2015-12-31 | $381.00K 10-K · filed 2017-03-30 |
| 2014-12-31 | $14.00K 10-K · filed 2016-03-30 |
| 2013-12-31 | $14.00K 10-K · filed 2015-03-31 |
| 2012-12-31 | $898.00K 10-K · filed 2014-03-26 |
| 2011-12-31 | $885.00K 10-K · filed 2013-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |